Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression release_vwr4ae5ovva7hodi5hdszmq7ka

by Cuiping Wu, Jinmei Zhang, Xiangang Cao, Qian Yang, Dequan Xia

Published in Medical Science Monitor.

2016   Volume 22, p2685-90


BACKGROUND Bile duct carcinoma is a common digestive tract tumor with high morbidity and mortality. As a kind of important non-coding RNA, microRNA (miR) plays an important role in post-transcriptional regulation. MiR-122 is the most abundant miR in the liver. Multiple studies have shown that miR-122 level is reduced in a variety of liver tumors and can be used as a specific marker for liver injury. P53 is a classic tumor suppressor gene that can induce tumor cell apoptosis through various pathways. Whether miR-122 affects p53 in bile duct carcinoma still needs investigation. MATERIAL AND METHODS miR inhibitor or mimics was transfected to bile duct carcinoma cells to evaluate its function on proliferation, invasion, apoptosis, and p53 expression. RESULTS MiR-122 overexpression reduced cell invasion and migration ability, and inhibited cell apoptosis and p53 expression. Inhibiting miR-122 caused the opposite results. CONCLUSIONS Upregulating miR-122 can suppress bile duct carcinoma cell proliferation and induce apoptosis. MiR-122 could be used as a target for bile duct carcinoma treatment, which provides a new strategy for cholangiocarcinoma patients.
In text/plain format

Archived Files and Locations

application/pdf  590.5 kB
europepmc.org (repository)
web.archive.org (webarchive)
Read Archived PDF
Type  article-journal
Stage   published
Date   2016-07-29
Language   en ?
PubMed  27472451
PMC  PMC4976756
Container Metadata
Open Access Publication
Not in DOAJ
Not in Keepers Registry
ISSN-L:  1234-1010
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 3736947b-c5d5-4fec-9529-54e4f1392bc9